Accucaps maker describes need for gel-cap manufacturing finesse

"This is an industry that relies on your brains, not your brawn," says ops VP Glen Harron of gel-cap maker Accucaps. "It relies on a very self-disciplined workforce. People need to keep a slow, methodical pace; you need to be accurate, accurate, accurate." Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.